TW200706174A - Indole compounds - Google Patents

Indole compounds

Info

Publication number
TW200706174A
TW200706174A TW094136522A TW94136522A TW200706174A TW 200706174 A TW200706174 A TW 200706174A TW 094136522 A TW094136522 A TW 094136522A TW 94136522 A TW94136522 A TW 94136522A TW 200706174 A TW200706174 A TW 200706174A
Authority
TW
Taiwan
Prior art keywords
indole compounds
angiogenesis
formula
methods
treating cancer
Prior art date
Application number
TW094136522A
Other languages
Chinese (zh)
Inventor
Hsing-Pang Hsieh
Jing-Ping Liou
Jang-Yang Chang
Chun-Wei Chang
Original Assignee
Nat Health Research Institutes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/195,531 external-priority patent/US7528165B2/en
Application filed by Nat Health Research Institutes filed Critical Nat Health Research Institutes
Publication of TW200706174A publication Critical patent/TW200706174A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

This invention relates to methods of inhibiting tubulin polymerization and treating cancer and other angiogenesis-related disorders with indole compounds of the formula: wherein L1, L2, R1, R2, Ra, Rb, Rc, Rd, and Re are defined herein.
TW094136522A 2005-08-01 2005-10-19 Indole compounds TW200706174A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/195,531 US7528165B2 (en) 2001-12-13 2005-08-01 Indole compounds

Publications (1)

Publication Number Publication Date
TW200706174A true TW200706174A (en) 2007-02-16

Family

ID=57910730

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094136522A TW200706174A (en) 2005-08-01 2005-10-19 Indole compounds

Country Status (1)

Country Link
TW (1) TW200706174A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109369502A (en) * 2018-12-14 2019-02-22 宜春学院 A kind of indomethacin derivatives and its preparation method and application

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109369502A (en) * 2018-12-14 2019-02-22 宜春学院 A kind of indomethacin derivatives and its preparation method and application

Similar Documents

Publication Publication Date Title
NL301145I2 (en) Tirbanibulin
EA200970737A1 (en) OXABICYCLOPTANES AND OXABICYCLOPTENS
PH12015500248A1 (en) Humanized anti-cxcr5 antibodies, derivatives thereof and their uses
EA200900798A1 (en) INDOL-4-ILPYRIMIDINYL-2-ILAMINE DERIVATIVES AND THEIR APPLICATION AS INHIBITORS OF CYCLIN-DEPENDENT KINASE
MX2009006627A (en) Quinazolines for pdk1 inhibition.
MX2009012625A (en) Methods of treating, diagnosing and detecting fgf21-associated disorders.
WO2007123892A3 (en) Raf inhibitors and their uses
MX2009006536A (en) Organic compounds and their uses.
EA200970738A1 (en) AKT ACTIVITY INHIBITORS
ZA200702973B (en) Disubstituted pyrazolobenzodiazepines useful as inhibitors for CDK2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer
GEP20125664B (en) Condensed heterocyclic derivatives and application thereof
NO20091661L (en) Use of pegylated IL-10 to treat cancer
MX2009013082A (en) C3b antibodies and methods for the prevention and treatment of complement- associated disorders.
EA201000016A1 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER, TUMORS AND DISTURBANCES ASSOCIATED WITH TUMORS
EA200701396A1 (en) TRIAZOLOPHTHALASINS AS PDE-2 INHIBITORS
WO2007087245A3 (en) Ret tyrosine kinase inhibition
BRPI0715763A2 (en) treating or preventing cancers by overexpressing reg4 or kiaa0101
EA200971068A1 (en) TRIAZOLYLAMINOPYRIMIDINE COMPOUNDS
AP2886A (en) 6.7-Dialkoxy quinazoline derivatives useful for treatment of cancer related disorders
EA200802072A1 (en) LIKOPIN FOR THE TREATMENT OF INFRINGEMENT OF SUBSTANCES
BRPI0820440A2 (en) Aldh-2 inhibitors in the treatment of psychiatric disorders.
BRPI0808043A2 (en) TRICYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF IRON DISORDERS.
BRPI0818170A2 (en) 5-cyanothienopyridines for the treatment of tumors.
TW200740766A (en) Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6-ligands
MX2012005155A (en) Quinazoline compounds.